top of page
it's where dermatology lives



VIDEO: Roflumilast shows efficacy in 95% of plaque psoriasis patients
Roflumilast showed significant improvement in disease severity in 95% of plaque psoriasis patients by week 8.
Jeremy Visser
Nov 1, 20231 min read


VIDEO: Study suggests Covid-19 may be associated with increased incidence of psoriasis
Patients who have contracted Covid-19 may have a higher risk of developing psoriasis and other immune-mediated inflammatory diseases.
Jeremy Visser
Oct 25, 20231 min read


VIDEO: Colloidal oatmeal as efficacious as barrier cream in Black children with AD
Colloidal oatmeal 1% is efficacious in treating mild-to-moderate AD in Black children, according to a recent study.
Jeremy Visser
Oct 18, 20231 min read


EADV 2023 Day 4 Afternoon: JAK Inhibitors and Inflammatory Skin Disease
Dr. Ronald B. Vender gives insights into JAK inhibitors and patient aspects of skin diseases at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 15, 20231 min read


EADV 2023 Day 4 Morning: Congress Presentations of Interest
Dr. Ronald B. Vender recaps the most popular presentations at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 15, 20231 min read


EADV 2023 Day 3 Evening: Abrocitinib for Prurigo Nodularis in Chronic Pruritis
Dr. Fiona Lovegrove reports on a late breaking presentation about the efficacy and safety of abrocitinib at the 2023 EADV Congress in Berlin
Jeremy Visser
Oct 14, 20231 min read


EADV 2023 Day 3 Afternoon: Efficacy and Safety of Rezpegaldesleukin
Dr. Fiona Lovegrove reports on the late breaking presentation on rezpegaldesleukin at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 14, 20231 min read


EADV 2023 Day 3 Morning: Bullous Diseases
Dr. Fiona Lovegrove reports on bullous diseases at the 2023 EADV Congress in Berlin.
Jeremy Visser
Oct 14, 20231 min read
Featured Posts




bottom of page